Novel diastereomers with opposite chirality at ruthenium formed by N7,.alpha.-PO4 chelation of 5'-dGMP to the antimetastatic agent trans-RuCl2(DMSO)4: NMR and CD evidence
- 1 August 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 111 (18) , 7068-7071
- https://doi.org/10.1021/ja00200a026
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Macrochelate complexes of purine 5'-nucleotide triphosphates and monophosphates: definitive multinuclear NMR evidence supported by molecular mechanics calculationsJournal of the American Chemical Society, 1988
- The mechanism of action of platinum antitumor drugsPure and Applied Chemistry, 1987
- PRECLINICAL EVALUATION OF DICHLOROBIS(1-PHENYLBUTANE-1,3-DIONATO)TITANIUM(IV) AND BUDOTITANE - 2 REPRESENTATIVES OF THE NEW CLASS OF ANTITUMOR-ACTIVE BIS-BETA-DIKETONATO METAL-COMPLEXES1986
- Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasmsEuropean Journal of Cancer and Clinical Oncology, 1984
- Chiral probes for the handedness of DNA helices: enantiomers of tris(4,7-diphenylphenanthroline)ruthenium(II).Proceedings of the National Academy of Sciences, 1984
- Tris(phenanthroline)ruthenium(II): stereoselectivity in binding to DNAJournal of the American Chemical Society, 1984
- The interactions of cis- and trans-diammineplatinum compounds with 5′-guanosine monophosphate and 5′-deoxyguanosine monophosphate. A proton nmr investigationJournal of Inorganic Biochemistry, 1980